As GTSE1 was reported to serve as a regulator of gastric cancer against cisplatin therapy11, we then investigated whether GTSE1 could affect the anti-tumour effects of 5-fluorouracil (5-FU) in HCC. This evidence concerns the gene GTSE1 and gastric cancer.